| Sokley Khoi, PHD | |
|
2515 Santa Clara Ave, Suite 209, Alameda, CA 94501-4660 | |
| (510) 393-6224 | |
| (510) 521-8459 |
| Full Name | Sokley Khoi |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 2515 Santa Clara Ave, Alameda, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881087898 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY16685 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sokley Khoi, PHD 3011 Bayview Dr, Alameda, CA 94501-6304 Ph: (510) 393-6224 | Sokley Khoi, PHD 2515 Santa Clara Ave, Suite 209, Alameda, CA 94501-4660 Ph: (510) 393-6224 |
News Archive
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Everywhere you look, Medicaid seems to be in jeopardy.
Researchers from the Department of Microbiology & Immunology, Dalhousie University, University of Calgary, and Department of Biochemistry and Molecular Biology, University of British Columbia, Canada, worked with human coronaviruses in cell cultures to look for drugs that might prevent accumulation and replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Working in collaboration with Kiel University, researchers at the Kiel- based Collagen Research Institute (CRI) have demonstrated the stimulating effect of special bioactive collagen peptides (FORTIGEL(R)) in the context of cell experiments. Last weekend the CRI presented its research findings at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal.
Using an in-home portable air cleaner (PAC) can significantly reduce exposure to fine-particle air pollutants - a major risk factor for cardiovascular events in people with pre-existing heart disease, reports a pilot study in the July issue of Journal of Cardiopulmonary Rehabilitation and Prevention.
Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, today announced that the first patient has been treated in a Phase 2 clinical trial of intravenous treatment with JX-594 for patients with advanced hepatocellular carcinoma (HCC), or liver cancer, who have not received treatment with sorafenib—the current standard of care for this patient population.
› Verified 5 days ago
Leonard Ferrara, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1150 Ballena Blvd, Suite113, Alameda, CA 94501 Phone: 510-599-8392 | |
Daniel J Libby, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1505 Webster St, Alameda, CA 94501 Phone: 516-680-8362 | |
Dr. Tucker Peck, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2103 San Jose Ave, Alameda, CA 94501 Phone: 520-485-9411 Fax: 844-227-8699 | |
Hawlan Ng, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1415 Webster St Unit 3076, Alameda, CA 94501 Phone: 510-409-3928 | |
Mrs. Nusrat Sultan, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1025 Atlantic Ave Ste 101, Alameda, CA 94501 Phone: 510-268-8120 | |
Joyce Ray Saad, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2258 Santa Clara Ave, Suite 4, Alameda, CA 94501 Phone: 510-522-3076 | |
Dr. Merry Thomas, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2245 Santa Clara Ave Ste 200, Alameda, CA 94501 Phone: 510-749-9040 Fax: 510-864-8040 |